Simvita Tablet 20 Milligrams (Simvastatin)
Simvastatin 20mg
Tablet · Prescription medication
Light Pharm Tech Co., Ltd.
MFDS item code 202002293 · Approved 2020.04.02
This product's status changed to Expired on 2025.04.02. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of hyperlipidemia (including familial hyperlipidemia in children), prevention of cardiovascular disease
This medication reduces the risk of cardiovascular diseases. It lowers the risk of mortality from coronary artery disease, non-fatal myocardial infarction, and stroke in adults with a history of coronary artery disease, diabetes, peripheral vascular disease, or stroke. It also has the effect of reducing the risk associated with vascular bypass surgery. In patients with hyperlipidemia, it helps to lower high cholesterol and triglyceride levels and increase good cholesterol (HDL). It is also used as an adjunct to diet for pediatric patients with heterozygous familial hypercholesterolemia to improve blood lipid levels. Overall, it is used to protect cardiovascular health and manage dyslipidemia.
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. 1. Reduction of risk of cardiovascular disease Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. The recommended dose is 5 ~ 40 mg of this medicine once daily in the evening. Adjust the dose appropriately before starting treatment based on the initial LDL cholesterol level, treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter to adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Due to the increased risk of myopathy, including rhabdomyolysis, use of the 80 mg dose of this medicine is restricted to patients who have been taking 80 mg for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use), particularly during the first year of treatment. 2) See below for the recommended doses for patients receiving this medicine with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and for certain patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment) (see 6. Interactions under Precautions for Use). (1) Administration to patients with homozygous familial hypercholesterolemia Based on the results of controlled clinical trials, administer 40 mg of this medicine once daily in the evening to patients with homozygous familial hypercholesterolemia. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not feasible. (2) In elderly patients, a maximum reduction in cholesterol levels may be achieved with a daily dose of 20 mg of this medicine. (3) Administration to patients receiving verapamil, diltiazem, or dronedarone When this medicine is coadministered with verapamil, diltiazem, or dronedarone, the dose of this medicine should not exceed 10 mg daily. (4) Administration to patients receiving amiodarone, amlodipine, or ranolazine When this medicine is coadministered with amiodarone, amlodipine, or ranolazine, the dose of this medicine should not exceed 20 mg daily. (5) Coadministration with other lipid-lowering agents This medicine is effective when administered alone or in combination with a bile acid sequestrant. When this medicine is coadministered with a fibrate (excluding gemfibrozil (see 2. Do not administer to the following patients under Precautions for Use) and fenofibrate), the dose of this medicine should not exceed 10 mg daily. (6) Administration to patients with renal impairment As this medicine is not extensively excreted by the kidneys, no dose adjustment is necessary for patients with mild to moderate renal impairment. However, in patients with severe renal impairment, start with an initial dose of 5 mg daily and monitor carefully.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg daily, and the recommended maximum dose is 40 mg daily. Adjust the dose as appropriate for each patient according to the recommended treatment goal. Allow an interval of 4 weeks or longer between dose adjustments.
This drug is primarily used to lower cholesterol levels in the blood and reduce the risk of cardiovascular diseases. This drug can cause muscle abnormalities, so if symptoms of muscle pain or weakness occur, you should inform your doctor immediately. Particularly, the risk of myopathy increases when taking high doses or certain other medications together. As this drug is metabolized in the liver, caution is necessary for patients with poor liver function or those who consume a lot of alcohol. If liver function test results are abnormal, administration should be avoided or done according to the doctor's guidance. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this drug, and if pregnancy is confirmed during treatment, it should be immediately discontinued. This drug interacts with many specific drugs; co-administration can increase the risk of side effects, so if other medications are being taken, you must inform your doctor or pharmacist. Particularly, caution is needed when taking in conjunction with potent CYP3A4 inhibitors, some antifungals, antibiotics, immunosuppressants, and certain heart medications. Elderly patients or those with impaired kidney function, as well as patients with hypothyroidism, have a higher risk of muscle problems when using this drug, thus careful monitoring is essential. If you experience unexplained muscle pain, tenderness, or weakness that persists or worsens during treatment, consult with healthcare personnel immediately, and if necessary, blood tests should be conducted to check for muscle damage. This medication may rarely cause side effects such as liver dysfunction, allergic reactions, skin rashes, dyspepsia, headache, etc., so if any unusual symptoms arise, consult a doctor. When storing this medication, keep it out of the reach of children, store it in its original container, and do not transfer it to another container for safety.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent contact with air or moisture, and ideally kept at room temperature between 1 to 30 degrees Celsius. Storing it this way will help maintain the drug's effectiveness and prevent degradation.
Pale yellow oval-shaped film-coated tablets
30 tablets/bottle, 100 tablets/bottle, 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Simvastatin 20mg
Tablet · Prescription medication
Light Pharm Tech Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Jongkundang Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Dong-A ST Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Korea Hutech Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Yuhan Corporation

Simvastatin 40mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Dongsung Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.